Blood Sugar Control: They stimulate the pancreas to release insulin when blood sugar is high and block the release of glucagon, thereby stabilizing glucose levels
For comparison, The Wall Street Journal reported that Eli Lillys current drug Zepbound produced an average weight loss of about 22.5%, while Novo Nordisks Wegovy typically results in weight loss under 20%
Glucagon receptor activation is thought to increase energy expenditure and promote fat breakdown (lipolysis), which may help explain the substantial weight loss observed in early-phase trials however, these mechanistic effects have not yet been fully characterised in humans and should be regarded as preliminary findings
Some guys have shared "Before and After Semaglutide Men" pictures to show how their belly fat has changed
"A Randomised Controlled Clinical Trial in Type 2 Diabetes Comparing Semaglutide to Placebo and Liraglutide"
Always consult a qualified healthcare provider before starting, stopping, or changing any treatment plan
